Nevertheless, breast cancer with high immune activity not only enriched immune-related gene sets, but also enriched pro-cancer gene sets: KRAS signaling, PI3K/AKT/MTOR signaling, and apical surface gene sets. This evidence concerns the gene KRAS and breast carcinoma.